CLYM Climb Bio, Inc.: Earnings per share for the last twelve months

Official company branding of Climb Bio Inc (CLYM)

The fundamental TTM net income per share in the chronology of the indicator on the GURU.Markets chart is based on the potential of B-cell therapy for patients with autoimmune pathologies, where -0.82 expresses the latest level of the metric. Climb Bio Inc (CLYM) is creating a closed patent perimeter through the development of monoclonal antibodies, while seamlessly delegating clinical trials to external contractors without losing control over intellectual property.

Climb Bio Inc (CLYM) - Net earnings per share (EPS TTM) from 10/04/2024 to 11/11/2026

Analytical breakdowns and data insights for company Climb Bio Inc. (CLYM)

- current quotes and average value forecast:
Price Chart Climb Bio Inc|CLYM - Consensus Target
- company stock capitalization data:
Market Value Climb Bio Inc.|CLYM - Real Price to Acquire Entire Company
- shareholders' equity book value data:
Accounting Value per Share Climb Bio|CLYM - Book Capitalization|Market Value to Book Value Ratio climbbio.com|CLYM - Total Business Assets
- debt and liquidity data:
Total Debt to Capital Climb Bio Inc|CLYM - Long-Term Liabilities to Capital|Short-Term Debt to Capital Climb Bio, Inc.|CLYM - Company Total Debt|Debt to Book Capitalization Ratio Climb Bio Inc.|CLYM - Company Long-Term Debt|Company Short-Term Debts Climb Bio|Quick Liquidity climbbio.com
- earnings and valuation multiples indicators:
CLYM - Net Income|Projected Future Earnings Climb Bio Inc|CLYM - Price to Earnings Ratio|Projected Price to Earnings Climb Bio|CLYM - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple Climb Bio Inc.|CLYM - Profit before payment of interest, taxes and amortization|Net earnings per share (EPS TTM) Climb Bio|CLYM - Net earnings per share for the last four quarters|Year-over-year earnings per share growth for the last twelve months climbbio.com|CLYM - Earnings per share growth rate in current year|Expected earnings per share growth for next year Climb Bio Inc
Initial company analysis:CLYM - Climb Bio Inc
Manufactured products of Climb Bio Inc.

Investors utilize this indicator to assess the real yield of each stock, determining the business's intrinsic resilience to market shocks. The calculation of net income per share over 12 months is based on trailing income, which in the case of Climb Bio Inc (CLYM) may stagnate due to sanction restrictions and logistical disruptions during the conduct of global clinical trials.

Competitor analysis for Climb Bio Inc

ARGX - Earnings per share for the last twelve months|biontech.de (BNTX) - Net earnings per share for the last 12 months|Abivax Pharma (ABVX) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months ADMA Biologics Inc|Net earnings per share for the last 12 months PTGX|Net earnings per share (EPS TTM) Immunovant Therapeutics|Earnings per share for the last twelve months Kiniksa Pharmaceuticals (KNSA)|grifols.com - Earnings per share for the last 12 months|Net earnings per share (EPS TTM) ADPT (Adaptive Biotechnologies Corporation)|Celldex Therapeutics Inc (CLDX) - Net earnings per one share for the last twelve months|Aurinia Pharma - Net earnings per share (EPS TTM)|BioCryst Corp (BCRX) - Net earnings per share for the last 12 months|Vera Therapeutics, Inc. (VERA) - Earnings per share for the last twelve months|DNTH (dianthustx.com) - Earnings per share for the last twelve months|PHVS (Pharvaris) - Net earnings per share (EPS TTM)|AbCellera Biologics Inc (ABCL) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Tourmaline Corp (TRML)|Net earnings per share for the last 12 months Precigen Corp PGEN|Net earnings per share (EPS TTM) PHAR (Pharming Group N.V.)|nektar.com - Earnings per share for the last twelve months|UPB: Net earnings per share for the last 12 months|Earnings per share for the trailing year ZBIO (Zenas Bio)|IMNM: Net earnings per share (EPS TTM)|GOSS (Gossamer Bio Corp.) - Earnings per share for the last twelve months|KALV (KalVista Pharmaceuticals) - Net earnings per share (EPS TTM)|septerna.com (SEPN) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Pieris Pharmaceuticals, Inc. (PVLA)|SVRA - Net earnings per one share for the last twelve months|Rigel Pharmaceuticals Inc - Net earnings per share for the last 12 months|Earnings per share for the trailing year ANAB|Astria Therapeutics - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters engene.com ENGN|RAPT Therapeutics, Inc. (RAPT) - Earnings per share for the last twelve months|Earnings per share for the last 12 months JBIO|ACRS (Aclaris) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months Kyverna Therapeutics, Inc (KYTX)|Net earnings per share (EPS TTM) TLSA|Net earnings per share for the last 12 months cabalettabio.com CABA|Earnings per share for the last twelve months Ventyx Biosciences, Inc. VTYX|Theratechnologies, Inc. - Earnings per share for the last twelve months|AVTX: Net earnings per share for the last 12 months|Net earnings per one share for the last twelve months Eledon Pharmaceuticals, Inc|Agenus (AGEN) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months Zura Bio Ltd|Earnings per share for the last twelve months aTyr Pharma|Adagene Corp - Earnings per one share for the last 12 months|Net earnings per share (EPS TTM) IMA|STTK (shattucklabs.com) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) EQ (Equillium)|Net earnings per share (EPS TTM) Connect Biopharma Holdings CNTB|IMUX - Earnings per share for the last twelve months|Earnings per share for the trailing year ATRA (Atara Biotherapeutics)|inflarx.de (IFRX) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months X4 Pharmaceuticals, Inc|ACET (Adicet Bio Inc.) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) Celularity Corp|Net earnings per share for the last 12 months INMB (INmune Bio)|BRNS (Barinthus Biotherapeutics PLC) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) KZR (Kezar Life Sciences, Inc)|Net earnings per share for the last four quarters SAB Biotherapeutics Inc (SABS)|AKTX - Earnings per share for the last twelve months|Enlivex Therapeutics (ENLV) - Net earnings per share for the last 12 months|q32bio.com (QTTB) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months GeoVax Labs|Net earnings per share for the last 12 months EDSA|Net earnings per share (EPS TTM) iBio Corporation|Earnings per share for the last twelve months Carisma Therapeutics (CARM)|xtlbio.com - Earnings per share for the last 12 months|Net earnings per share (EPS TTM) BOLT (Bolt Biotherapeutics, Inc.)|HCW Biologics, Inc. (HCWB) - Net earnings per one share for the last twelve months|Aptevo - Net earnings per share (EPS TTM)|AIM ImmunoTech, Inc. (AIM) - Net earnings per share for the last 12 months|aditxt.com (ADTX) - Earnings per share for the last twelve months|GRI (gribio.com) - Earnings per share for the last twelve months|XRTX (XORTX Therapeutics) - Net earnings per share (EPS TTM)|Vyome Holdings Inc. (HIND) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Revelation Bio (REVB)|Net earnings per share for the last 12 months Indaptus Corp INDP|Net earnings per share (EPS TTM) SCNI (Scinai Immunotherapeutics)|CalciMedica Inc - Earnings per share for the last twelve months|AFMD: Net earnings per share for the last 12 months|Earnings per share for the trailing year ALLK (Allakos Inc.)|HOOK: Net earnings per share (EPS TTM)|IGMS (IGM Biosciences) - Earnings per share for the last twelve months|ITOS (iTeos Therapeutics) - Net earnings per share (EPS TTM)|oceanbiomedical.com (OCEA) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months TC BioPharm (TCBP)|THRD - Net earnings per one share for the last twelve months